Plunkett Research Online: Ani Pharmaceuticals

ANI PHARMACEUTICALS (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ani Pharmaceuticals, formerly Alimera Sciences, Inc., is a pharmaceutical company that markets ILUVIEN for diabetic macular edema (DME) and non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant designed to reduce the frequenc.....


ANI PHARMACEUTICALS

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 678 990-5740
Fax:
Address: 6120 Windward Pkwy., Ste. 290
Alpharetta, GA 30005 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Nikhil LalwaniCEO/Pres.
Stephan CareyCFO
See More
Ani Pharmaceuticals, formerly Alimera Sciences, Inc., is a pharmaceutical company that markets ILUVIEN for diabetic macular edema (DME) and non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant designed to reduce the frequenc.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture